Contraline, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0 (NCT05134428) | Contraline, Inc | 2022-05-20 |
Track Contraline, Inc automatically
Every clearance here is in the API, with alerts when new ones post.